AI Analysis AI Analysis of HKMPY
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Hikma Pharmaceuticals plc. stock after losing 1.14%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 03, 2025 Loss -12.76%

The Hikma Pharmaceuticals plc. stock price fell by -1.14% on the last day (Monday, 17th Nov 2025) from $42.27 to $41.79. During the last trading day the stock fluctuated 0.579% from a day low at $41.55 to a day high of $41.79. The price has fallen in 6 of the last 10 days and is down by -12.76% for this period. Volume has increased on the last day by 475 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 587 shares were bought and sold for approximately $24.53 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $40.20 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.56% during the next 3 months and, with a 90% probability hold a price between $37.56 and $45.79 at the end of this 3-month period.

HKMPY Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, November 06, 2025, and so far it has risen 3.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Hikma Pharmaceuticals plc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $41.91 and $46.77. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Hikma Pharmaceuticals plc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Hikma Pharmaceuticals plc. stock

Hikma Pharmaceuticals plc. finds support from accumulated volume at $41.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.240 between high and low, or 0.579%. For the last week, the stock has had daily average volatility of 0.99%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HKMPY) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Hikma Pharmaceuticals plc. to open at $41.71, and during the day (based on 14 day Average True Range), to move between $41.20 and $42.38, which gives a possible trading interval of +/-$1.18 (+/-2.86%) up or down from last closing price. If Hikma Pharmaceuticals plc. takes out the full calculated possible swing range there will be an estimated 2.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $41.55 (0.57%) than the resistance at $45.89 (9.81%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Hikma Pharmaceuticals plc. stock A Buy?

Hikma Pharmaceuticals plc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.270 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $41.71 ( 0.192%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

HKMPY Performance

Trading levels for HKMPY

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 41.95 0.384%
R2 41.86 0.164%
R1 41.80 0.0280%
Price 41.79
S1 41.62 -0.412%
S2 41.56 -0.547%
S3 41.47 -0.767%

Accumulated Volume Support & Resistance Levels

Level Price
R3 49.04 17.35%
R2 47.74 14.24%
R1 45.89 9.81%
Price 41.79
S1 41.55 -0.574%
S2 40.98 -1.95%
S3 40.57 -2.91%

HKMPY Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Aug 18, 2025 Aug 18, 2025 Sep 29, 2025 $0.700 1.45%
2 Mar 21, 2025 Mar 21, 2025 May 12, 2025 $0.94 1.75%
3 Aug 19, 2024 Aug 19, 2024 Sep 30, 2024 $0.620 1.25%
4 Mar 21, 2024 Mar 21, 2024 May 13, 2024 $0.92 1.84%
5 Aug 05, 2023 Aug 11, 2023 Sep 25, 2023 $0.500 0.97%

FAQ

What is the symbol for Hikma Pharmaceuticals plc. Stock and on which exchange is it traded?
The symbol for Hikma Pharmaceuticals plc. is HKMPY and it is traded on the PINK (Pink Sheets).

Should I buy or sell Hikma Pharmaceuticals plc. Stock?
Hikma Pharmaceuticals plc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Hikma Pharmaceuticals plc. Stock?
Hikma Pharmaceuticals plc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Hikma Pharmaceuticals plc. Stock.

What's the current price of Hikma Pharmaceuticals plc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Hikma Pharmaceuticals plc. (HKMPY) share was $41.79.

What is the 52-week high and low for Hikma Pharmaceuticals plc. Stock?
The 52-week high for Hikma Pharmaceuticals plc. Stock is $59.26 and the 52-week low is $40.32.

What is the market capitalization of Hikma Pharmaceuticals plc. Stock?
As of the Nov 17, 2025, the market capitalization of Hikma Pharmaceuticals plc. is 4.612B.

When is the next earnings date for Hikma Pharmaceuticals plc.?
The upcoming earnings date for Hikma Pharmaceuticals plc. is Feb 24, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE